#United States #New York #Class Action #Gross Law Firm #Zenas BioPharma

Urgent Class Action Notice for Zenas BioPharma Shareholders

On May 15, 2025, The Gross Law Firm issued a crucial alert for shareholders of Zenas BioPharma, Inc. (NASDAQ: ZBIO), reminding them about the upcoming deadline to participate in a significant class action. Shareholders who acquired ZBIO shares during the designated class period are strongly encouraged to reach out to the firm to explore the possibility of being appointed as lead plaintiff. Importantly, interest in recovering losses does not necessitate this appointment.

Class Action Overview

This lawsuit is initiated on behalf of individuals who purchased or otherwise obtained Zenas BioPharma securities linked to the registration statement and prospectus issued during the company’s September 2024 IPO. Allegations within the complaint indicate that, during the designated period, the defendants delivered materially false or misleading statements and failed to disclose key information:

1. Zenas BioPharma significantly overstated its operational funding timeline relying on existing cash and expected IPO net proceeds.
2. Consequently, the public statements made by the defendants regarding the company’s financial status and risks were fundamentally untrustworthy and negligently prepared.

The firm emphasizes that shareholders must act swiftly since the registration deadline for this class action is June 16, 2025. Shareholders should ensure they do not procrastinate in their registration to join this critical lawsuit.

Next Steps for Shareholders

Interested shareholders who purchased ZBIO shares during the specified period should register to secure their place in the action. Upon registration, participants will be enrolled in a portfolio monitoring service that will keep them informed on developments regarding the case. This service is designed to provide continuous updates throughout the litigation process. Benefiting from this class action is entirely free of charge and poses no obligation.

Why Choose Gross Law Firm

The Gross Law Firm is a nationally recognized legal entity specializing in class action lawsuits, focused on safeguarding the rights of investors victimized by deceitful practices, fraud, and corporate misconduct. Their commitment to advocating for responsible business practices underscores their mission to ensure ethical corporate citizenship. The firm relentlessly pursues recovery for investors affected by the inflation of stock values due to the dissemination of misleading statements or the omission of critical information.

Contact Information

For those who wish to discuss their eligibility or have further questions, please reach out to:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: contact@grosslawfirm.com
Phone: (646) 453-8903

For those interested, complete details can be found on the Gross Law Firm website. This prompt action can be vital for shareholders wanting to recover potential losses linked with the recent events surrounding Zenas BioPharma.

Conclusion

Don’t miss out on your opportunity to recover losses from your ZBIO investments. Reach out to The Gross Law Firm before the June 16, 2025 deadline to participate in this ongoing class action lawsuit. The firm is dedicated to ensuring that shareholders get the justice they deserve through diligent and robust legal representation.